ASH

NYSE:ASH

Ashland

Add to Watchlist
  • Stock

49.03

−9.85%

−4.06

USD last updated 13/08 01:59:42

Last Close

53.09

12/08 22:30

Market Cap

4.67B

Beta: 1.00

Volume Today

1.46M

Avg: 411.24K

PE Ratio

29.48

PFCF: 14.21

Dividend Yield

1.63%

Payout:47.85%

SkyQuest Technology Group has published a market study on the global Antifog Additives Market, projecting it to grow from USD 415.47 million in 2024 to USD 595.38 million by 2032 at a CAGR of 4.6% during the 2025–2032 period. The market is segmented by type, application, and region, with Asia Pacific leading due to strong food and agricultural demand, particularly in China and India. Key drivers include material innovations such as bio-based and biodegradable antifog additives, rising sustainability demands, and regulatory pressure on plastic waste. Major players include Croda International, Evonik, BASF, Clariant, and others. Recent developments include Clariant’s eco-friendly additive (July 2024), BASF’s new food and automotive antifogging line (June 2024), and DSM’s novel antifog component for medical devices (August 2024). The report highlights the market’s role in driving innovation, economic growth, and sustainable packaging solutions across food, agriculture, pharmaceuticals, and automotive sectors.

newstrail.com

Ashland Inc. has declared a quarterly cash dividend of $0.415 per share, payable on September 15, 2025, to shareholders of record on September 1, 2025. The company, a global additives and specialty ingredients firm with a focus on environmental, social, and governance (ESG) initiatives, serves customers in over 100 countries.

globenewswire.com

United-Guardian, Inc. released financial results for Q2 and H1 2025, showing net sales and income declines compared to 2024 but with increases in pharmaceutical and medical lubricant sales. The company attributes reduced cosmetic ingredient sales to decreased purchases by its largest distributor, ASI, due to inventory overstock in Asia. United-Guardian is also launching a project to include its key product Renacidin® in additional drug formularies.

globenewswire.com

The pharmaceutical excipients market is projected to grow from USD 10.96 Bn in 2025 to USD 19.29 Bn by 2032, with a compound annual growth rate (CAGR) of 8.4%. The report highlights key players like Ashland Global Holdings Inc., BASF SE, and Innophos, along with market segmentation by product type, application, and geography. It provides insights into growth drivers, regulatory factors, and regional outlooks for North America, Europe, Asia-Pacific, and other regions.

openpr.com

The global acrylamide market is projected to grow from USD 3,955.4 million in 2025 to USD 5,911.6 million by 2035, driven by demand in water treatment, oil recovery, pulp and paper production, and textile processing. Key players like SNF Group, BASF SE, and Mitsui Chemicals Inc. are expanding production, while challenges such as health concerns and regulatory compliance persist.

openpr.com

    Description

    Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition s...Show More

    Earnings

    Earnings per Share (Estimate*)

    12345672018-11-062020-07-282022-02-012023-11-082024-11-06

    Revenue (Estimate*)

    200M400M600M800M1B1.20B1.40B2018-11-062020-07-282022-02-012023-11-082024-11-06

    *Estimate based on analyst consensus